Biocon Limited (BSE: 532523; NSE: BIOCON) today announced the appointment of Shreehas Tambe as its Chief Executive Officer & ...

Biocon's Siddharth Mittal steps down as MD & CEO; Shreehas Tambe, a 30-year company veteran with 61 patents, takes over from ...

Biocon is reducing its workforce as it finalizes the integration of its biologics and generics businesses, impacting hundreds ...

Biocon has announced a series of top-level leadership changes, including the appointment of Shreehas Pradeep Tambe as its new chief executive officer and managing director, effective 1 April 2026.

Biocon Limited has appointed Shreehas Tambe as its Chief Executive Officer and Managing Director, effective April 1, 2026, as ...

Biocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on ...

Biocon Ltd on Friday said it has appointed Shreehas Tambe as CEO & Managing Director, effective April 1, 2026.

Bengaluru: As Biocon prepares for a leadership transition on April 1, newly designated CEO and MD Shreehas Tambe has outlined ...

This leadership transition is part of the full integration of Biocon Biologics Limited as a wholly owned subsidiary of Biocon ...

Biocon share price has rallied over 20% in one month and has gained 17% in three months. The stock has surged 28% in six ...

Shares of Biocon fell on Friday, March 27, after Siddharth Mittal resigned as CEO and MD, who will transition to a new role ...